Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010
Role of genetic factors in COPD (alpha-1-antitrypsin deficiency and other factors) Source: Annual Congress 2005 - PG13 - COPD: genetic and environmental factors, epidemiology, socio-economic impact and preventative measures Year: 2005
Mannose-binding lectin (MBL) polymorphisms in children with post-infectious obliterant bronchiolitis (PIBO) Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013
Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 599s Year: 2006
Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Source: Eur Respir Rev 2006; 15: 224-225 Year: 2006
Tracing down the evolutionary history of Q0Ourém , a rare allele associated with severe alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Dose serum mannose binding lectin (MBL) influence allergic disorders? Source: Eur Respir J 2004; 24: Suppl. 48, 395s Year: 2004
Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021
Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
The predictive role of TLR4 +3725 G/C polymorphism in community-acquired pneumonia (CAP) severity course among young respondents with cytomegaloviral persistence (CMVP) Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Role of -511C>T/+3953C>T haplotypes of IL1B gene as risk factors of COPD Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
Interleukin-2 (IL-2) and interferon-γ(IF-γ) in idenitying severe community-acquired pneumonia (SCAP) clinical outcomes and complications Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Tumor necrosis factor-α (TNF- α) gene polymorphysm in work-related chronic bronchitis prognosis Source: Annual Congress 2012 - COPD beyond tobacco Year: 2012
Early re-colonization with pseudomonas aeruginosa (PA) after treatment: a possible risk factor for development of chronic infection in cystic fibrosis (CF) patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Thrombin generation test – As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Uncommonly common? Common variable immunoglobulin deficiency ‘masquerading‘ as sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012
Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014
Pneumonia severity index (PSI) at young patients and toll-like receptor 4 (TLR4) polymorphism interconnections: new diagnostic approach Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019